咖啡因咖啡的消费或戒断以减少心房:DECAF随机临床试验
Christopher X Wong1,2, Christopher C Cheung3, Gabrielle Montenegro1
1Division of Cardiology, University of California San Francisco.
JAMA
|November 9, 2025
概括
与禁食相比,每天平均摄入1杯咖啡因咖啡与心房的复发风险降低有关. 这项随机试验挑战了咖啡对肌肉功能障碍患者有助于节律失常的说法.
科学领域:
- 心脏病学
- 临床试验
- 电生理学
背景情况:
- 传统观点认为含咖啡因的咖啡会导致心律失常.
- 心房动是一种常见的心律失常, 咖啡是人们广泛饮用的饮料.
- 之前对咖啡因咖啡和AF复发的随机试验缺乏.
研究的目的:
- 研究咖啡因含咖啡的消费与戒断对复发性脑膜炎的影响.
- 评估每天适量摄入咖啡因咖啡的安全性和有效性.
主要方法:
- 这是一项前性,开放性,随机的临床试验,涉及200名患有持续性肌动脉.
- 参与者被随机分为1:1饮用含咖啡因的咖啡或在6个月内完全戒除咖啡因.
- 主要终点是临床检测到的AF或心房的复发.
主要成果:
- 与禁食组相比,咖啡因咖啡组的AF或心房的复发率较低 (47%).
- 咖啡因咖啡的摄入与39%的复发风险降低有关 (HR,0.61).
- 两组之间没有明显的不良反应差异.
结论:
- 适度的每日咖啡因含量可能与AF复发的风险降低有关.
- 这一发现挑战了人们对咖啡的传统看法,
- 进一步的研究可能会探索这种关联的具体机制.
相关概念视频
Experimental Designs
16.6K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
16.6K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Bioavailability Study Design: Healthy Subjects Versus Patients
137
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
137
Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Bioavailability Study Design: Single Versus Multiple Dose Studies
189
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
189
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K


